Diclofenac potassium is used to relieve pain and reduce inflammation and fever. It works quickly and is commonly used for headaches, muscle aches, menstrual cramps, and other types of short-term pain.[2] Cataflam is currently approved and in use across 10 indications[4].[1]
Cataflam is one of 225 small molecule programs targeting Respiratory tract infection. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1639 competitors in Non-Small Cell Lung Cancer
Cataflam
Yervoy
Gemzar
Lenvima
Imjudo
Vizimpro
Remeron
PD-1 Inhibitor
Tyrosine Kinase Inhibitor
Vidaza
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources